bst2222全球最奢华 - bst2222全球奢华游戏

Enterprise Email: mail.spf4.com

OA address

中文版 English

中文版 English

SUZHOU NO.4 PHARMACEUTICAL

SUZHOU NO.4 PHARMACEUTICAL

Staff

Working Guide: Job Title Evaluation ( https://hrss.suzhou.gov.cn/jsszhrss/zcpj/list.shtml )

Policies and Regulations: Epidemic Prevention and Control Policies ( https://wexin.menglangyun.com/hywechat/resources/yjfh/yjfh.html )

Knowledge and skills: GMP Forum ( http://gmpbbs.com/ )

Policies in the pharmaceutical and health industry

This article is an updated version of the series of policy review of Guojin Pharmaceutical.We have summarized the policies of the past year(2021)according to the investment logic of the secondary market.We hope to be able to judge the industry trends among the various policy details and provide
What are the tax benefits for biopharmaceuticals?

I.Preferential tax policies to promote investment:Venture capital is preferential.In order to encourage the development of small and medium-sized high-tech biomedical enterprises,venture capital enterprises that invest in unlisted small and medium-sized high-tech biomedical enterprises for more
The policy is clear! 1-year market exclusivity period for the first generic drug that challenges the patent and succeeds

(Reporter Luo Nan from this newspaper)Recently,the State Drug Administration and the State Intellectual Property Office jointly issued the"Measures for the Implementation of the Early Resolution Mechanism for Drug Patent Disputes(Trial)"(hereinafter referred to as the"Measures&quo

Index Previous 1 Next Last

Click to call the consultation hotline

Scan the QR code above to add Corporate WeChat

Scan the QR code above and add HR WeChat